Remove Develop Remove Invest Remove Platform Remove Thousand Oaks
article thumbnail

Amgen Invests $30M In Immatics, Up To $1 Billion In Future Payments

socalTECH

Thousand Oaks-based Amgen announced this morning that it has made a $30M investment in a German company developing cancer immunotherapy, Immatics Biotechnologies GmbH. The two said that Amgen will be responsible for the clinical development, manufacturing and commercialization worldwide of the new drugs.

article thumbnail

Amgen Re-Ups Investment In Sutro Biopharma

socalTECH

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M